Crispr Therapeutics shares owned by Bayesian Capital Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Bayesian Capital Management
from 13F filings
Historical chart of Bayesian Capital Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Bayesian Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Bayesian Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $2.8M | 41k | 68.16 |
| 2023-06-30 | $1.0M | 18k | 56.14 |
| 2022-12-31 | $520k | 13k | 40.65 |
| 2022-03-31 | $314k | 5.0k | 62.80 |
| 2020-03-31 | $263k | 6.2k | 42.42 |
| 2019-06-30 | $216k | 4.6k | 47.02 |
| 2019-03-31 | $339k | 9.5k | 35.68 |
More positions owned by Bayesian Capital Management
View all positions for Bayesian Capital Management